Fusion Pharmaceuticals Inc. Lessee, Operating Lease, Liability, to be Paid, after Year Five
Fusion Pharmaceuticals Inc. had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $12.40 million as of 2023-12-31, per its 10-K filed 2024-03-20.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2024-03-20
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $12.40M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $145.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $425.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2023-12-31 | $12.40M 10-K · filed 2024-03-20 |
| 2022-12-31 | $145.00K 10-K · filed 2023-03-16 |
| 2021-12-31 | $425.00K 10-K · filed 2022-03-17 |